Philip Morris International (PM) 21st Annual dbAccess Global Consumer Conference summary
Event summary combining transcript, slides, and related documents.
21st Annual dbAccess Global Consumer Conference summary
29 Jun, 20262024 performance outlook and financial guidance
Strong Q1 results and solid Q2 expected, with H1 showing robust organic growth in revenue and adjusted EPS before Forex impact.
Adjusted EPS growth before Forex is guided at 9%-11%, with reported growth revised upward due to easing Forex headwinds; full-year adjusted diluted EPS guidance raised for currency only to $6.26–$6.38, and $6.55–$6.67 excluding currency, up from $6.01 in 2023.
ZYN US volume target for 2024 is approximately 560 million cans, with new production capacity planned for 2025 and a new U.S. manufacturing site to support growth beyond 2025.
Combustible business remains resilient, with strong pricing power and volume stability in key markets.
Adjustments to EPS include asset impairment, exit costs, amortization of intangibles, and charges related to the war in Ukraine.
Product and market development
IQOS continues to grow in established markets like Japan and is gaining traction in Western and emerging markets such as Germany, Spain, Egypt, Indonesia, and Mexico.
ILUMA launch in Japan boosted market share due to improved user experience and innovative consumables.
ZYN is experiencing rapid growth in the US, with supply constraints being addressed through capacity expansion and normalization expected after Q3.
Nicotine pouches like ZYN are seen as a new, less risky way to consume nicotine, with potential to reach 10-20% of the US nicotine market.
Oral tobacco heritage helps ZYN adoption but is not essential for market success.
Strategic and capital allocation priorities
Focus remains on leveraging the combustible business to finance the transition to smoke-free products.
Share buybacks are considered when within net debt/EBITDA targets and absent major acquisitions.
No large M&A is currently planned; organic growth is the main priority.
Strategic review of the cigar business is ongoing, with future direction to be determined.
Latest events from Philip Morris International
- Smoke-free product momentum and multi-category strategy drive robust 2025 financial outlook.PM
2025 dbAccess Global Consumer Conference29 Jun 2026 - Smoke-free products drive growth, with ZYN ULTRA and IQOS expanding amid regulatory progress.PM
23rd annual dbAccess Global Consumer Conference2 Jun 2026 - Strong financial and smoke-free growth, dividend increase, and all board proposals but one approved.PM
AGM 20268 May 2026 - Adjusted EPS up 16% to $1.96, with smoke-free products now 43% of revenue, led by IQOS.PM
Q1 202624 Apr 2026 - Smoke-free growth and double-digit EPS gains fuel a strong 2026 outlook and new segment structure.PM
Q4 202521 Apr 2026 - Proxy materials corrected to confirm Werner Geissler as Compensation Committee Chair.PM
Proxy filing31 Mar 2026 - Board recommends all director and management proposals, but opposes the ESG filter report.PM
Proxy filing26 Mar 2026 - 2026 proxy outlines virtual meeting, strong results, governance, and Board opposition to ESG proposal.PM
Proxy filing26 Mar 2026 - Smoke-free products drive growth, margin expansion, and strong shareholder returns for 2026–28.PM
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026